Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes. (Q35242428)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes. |
scientific article |
Statements
Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes (English)
Michael J Haller
Stephen E Gitelman
Peter A Gottlieb
Stephen M Rosenthal
Jonathan J Shuster
Baiming Zou
Todd M Brusko
Maigan A Hulme
Clayton E Mathews
Mark A Atkinson
Desmond A Schatz
15 December 2014
1 reference
1 reference
1 reference